HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $497,807 | +15.8% | 13,035 | +33.3% | 0.08% | +78.6% |
Q2 2022 | $430,000 | -3.8% | 9,782 | -6.6% | 0.04% | +35.5% |
Q4 2020 | $447,000 | -66.1% | 10,471 | -78.7% | 0.03% | -73.0% |
Q2 2020 | $1,319,000 | +129.8% | 49,216 | +52.1% | 0.12% | +45.6% |
Q4 2019 | $574,000 | – | 32,348 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |